| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |